Current guidelines for psoriasis treatment: a work in progress.
Golbari, Nicole M, Martina L Porter, and Alexa B Kimball. 2018. “Current Guidelines for Psoriasis Treatment: A Work in Progress.”. Cutis 101 (3S): 10-12.
Search
Search results
13478 results found
Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension.
Kimball, Alexandra B, Thomas Luger, Alice Gottlieb, Luis Puig, Roland Kaufmann, Russel Burge, Chen-Yen Lin, and Gil Yosipovitch. 2018. “Long-Term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-Term Extension.”. Acta Dermato-Venereologica 98 (1): 98-102.
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Feldman, Steven R, Lawrence Green, Alexa B Kimball, Kimberly Siu, Yang Zhao, Vivian Herrera, Judit Nyirady, and Andrew F Alexis. 2017. “Secukinumab Improves Scalp Pain, Itching, Scaling and Quality of Life in Patients With Moderate-to-Severe Scalp Psoriasis.”. The Journal of Dermatological Treatment 28 (8): 716-21.
The temporal association between cutaneous T-cell lymphoma and psoriasis: implications for common biologic processes.
Donigan, J M, C Snowden, J B Carter, and A B Kimball. 2016. “The Temporal Association Between Cutaneous T-Cell Lymphoma and Psoriasis: Implications for Common Biologic Processes.”. Journal of the European Academy of Dermatology and Venereology : JEADV 30 (10): e31-e32.
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
Thaçi, Diamant, Ron Vender, Menno A de Rie, Curdin Conrad, David M Pariser, Bruce Strober, Veerle Vanvoorden, et al. 2023. “Safety and Efficacy of Bimekizumab through 2 Years in Patients With Moderate-to-Severe Plaque Psoriasis: Longer-Term Results from the BE SURE Randomized Controlled Trial and the Open-Label Extension from the BE BRIGHT Trial.”. The British Journal of Dermatology 188 (1): 22-31.
Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Kimball, Alexa B, Lyn Guenther, Sunil Kalia, Elke M G J de Jong, Kimberly Parnell Lafferty, Dan Y Chen, Wayne Langholff, and Neil H Shear. 2021. “Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).”. JAMA Dermatology 157 (3): 301-6.
Impact of childhood atopic dermatitis on life decisions for caregivers and families.
Capozza, K, A Schwartz, J E Lang, J Chalmers, J Camilo, K Abuabara, K Kelley, et al. 2022. “Impact of Childhood Atopic Dermatitis on Life Decisions for Caregivers and Families.”. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (6): e451-e454.
A pilot investigation of muscle integrity in patients with ADSSL1 myopathy using electrical impedance myography.
Farid, Alexander Rashad, Emma Golden, Alice Hu, Sara Robicheau, Seward Rutkove, Walla Al-Hertani, and Jaymin Upadhyay. 2023. “A Pilot Investigation of Muscle Integrity in Patients With ADSSL1 Myopathy Using Electrical Impedance Myography.”. Muscle & Nerve 68 (5): 775-80.
Global neurology: It's time to take notice.
Rutkove, Seward B, Annapurna Poduri, Robert G Holloway, Scott L Pomeroy, and Justin C McArthur. 2023. “Global Neurology: It’s Time to Take Notice.”. Annals of Clinical and Translational Neurology 10 (5): 842-45.
Diminished muscle integrity in patients with fibrodysplasia ossificans progressiva assessed with at-home electrical impedance myography.
Farid, Alexander, Emma Golden, Sara Robicheau, Alice Hu, Kin Cheung, Paul B Yu, Seward B Rutkove, and Jaymin Upadhyay. 2022. “Diminished Muscle Integrity in Patients With Fibrodysplasia Ossificans Progressiva Assessed With At-Home Electrical Impedance Myography.”. Scientific Reports 12 (1): 20908.